Holdings
Ikarian Capital, LLC
As of Sep 30, 2026, Ikarian Capital, LLC reported 118 positions worth US$472M. Largest: Kodiak Sciences Inc, Abivax SA and Vaxcyte, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Kodiak Sciences Inc | 533K | US$50.5M | −527K | Sep 30, 2026 |
| Abivax SA | 286K | US$28.4M | −42,726 | Sep 30, 2026 |
| Vaxcyte, Inc. | 400K | US$22.8M | +11,783 | Sep 30, 2026 |
| Arcus Biosciences, Inc. | 735K | US$19M | +230K | Sep 30, 2026 |
| Celldex Therapeutics, Inc. | 519K | US$16.8M | +40,000 | Sep 30, 2026 |
| Amylyx Pharmaceuticals, Inc. | 561K | US$16.3M | +444K | Sep 30, 2026 |
| Vera Therapeutics, Inc. | 400K | US$12.9M | +90,000 | Sep 30, 2026 |
| Alto Neuroscience, Inc. | 482K | US$12.3M | +75,000 | Sep 30, 2026 |
| Cogent Biosciences, Inc. | 370K | US$11.9M | no change | Sep 30, 2026 |
| ANI Pharmaceuticals, Inc. | 149K | US$10.8M | −123K | Sep 30, 2026 |